Genetic Technologies Limited (GENE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GENE Annual Balance Sheets →
A period-by-period view of the balance sheet from Genetic Technologies Limited to Dec 31 2021 helps clarify how Jun 30 2024's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
0 0 0 (Dec 31 2021)
Assets
Cash And Cash Equivalents1.02
Cash & Short-term Investments1.00
Inventories0.21
Other Current Assets2.47
Total Current Assets3.70
Equipment/Property/Plant Net0.05
Goodwill net1.78
Deferred Tax Assets0.08
Other Assets, Noncurrent0.57
Total Assets6.19
Liabilities
Accounts Payable0.00
Other Liabilities, Current3.62
Current Provisions0.57
Total Current Liabilities4.20
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.08
Noncurrent Provisions0.08
Total Liabilities4.36
Stockholders' Equity
Other Equity1.83
Common Stockholder's Equity1.83
Total Stockholder's Equity1.83
Liabilities & Stockholder's Equity6.19
4 historic quarters locked

Sign in to unlock the full Genetic Technologies Limited balance sheet history.

About Genetic Technologies Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20240630)
  • Filed with the SEC: September 30, 2024
  • Source: form20-f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-038693

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.